- Practice your HAE trading strategies and win cash in our stock game.
NEW YORK ( TheStreet) -- Haemonetics Corporation (NYSE: HAE) hit a new 52-week high Wednesday as it traded at $64.84 compared with its previous 52-Week high of $64.83. Haemonetics is changing hands at $64.77 with 33,792 shares traded as of 2:47 p.m. ET. Average volume has been 164,200 shares over the past 30 days. Haemonetics has a market cap of $1.6 billion and is part of the health care sector and health services industry. Shares are up 1.6% year to date as of the close of trading on Tuesday. Haemonetics Corporation, a healthcare company, provides blood management solutions to plasma and blood collectors, blood banks, hospitals and hospital service providers, and health organizations in the United States and internationally. The company has a P/E ratio of 25.4, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.1.